New potential key pathway in patients with ALL
At the 2022 ASH Conference in December, a study was presented that focuses on uncovering key pathways in leukemic-stromal cells through Leukemia-Derived Extracellular Vesicles (LEV) in patients with acute lymphoblastic leukemia (ALL). MD and PhD Signe Modvig from Rigshospitalet in Denmark discussed the findings of this study in this MEDtalk.
Get access to the article
If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.